Ji L, Huang B, Ren D, Wei X, Liu L, Bi Y
CNS Neurosci Ther. 2025; 31(3):e70275.
PMID: 40019038
PMC: 11868986.
DOI: 10.1111/cns.70275.
Murphy K, Gennusa J, Dalcin A, Cook C, Goldsholl S, Fink T
Front Psychiatry. 2025; 16:1446985.
PMID: 39958153
PMC: 11825777.
DOI: 10.3389/fpsyt.2025.1446985.
Williams J, Tubiolo P, Gil R, Zheng Z, Silver-Frankel E, Haubold N
medRxiv. 2025; .
PMID: 39763546
PMC: 11702713.
DOI: 10.1101/2024.12.18.24319241.
Smyrnis A, Theleritis C, Ferentinos P, Smyrnis N
Front Psychiatry. 2024; 15:1463974.
PMID: 39691789
PMC: 11650710.
DOI: 10.3389/fpsyt.2024.1463974.
Zheng Y, Zhou X, Chen K, Fu Z, Zhang P, Zhu Q
BMC Psychiatry. 2024; 24(1):876.
PMID: 39627737
PMC: 11613812.
DOI: 10.1186/s12888-024-06330-w.
Effectiveness of a Videoconference-Based Cognitive Behavioral Therapy Program for Patients with Schizophrenia: Pilot Randomized Controlled Trial.
Katsushima M, Nakamura H, Shiko Y, Hanaoka H, Shimizu E
JMIR Form Res. 2024; 9:e59540.
PMID: 39610049
PMC: 11775488.
DOI: 10.2196/59540.
Meta-analyses of epigenetic age acceleration and GrimAge components of schizophrenia or first-episode psychosis.
Shirai T, Okazaki S, Tanifuji T, Numata S, Nakayama T, Yoshida T
Schizophrenia (Heidelb). 2024; 10(1):108.
PMID: 39548083
PMC: 11568310.
DOI: 10.1038/s41537-024-00531-8.
Neurostructural changes in schizophrenia and treatment-resistance: a narrative review.
Paul T, See J, Vijayakumar V, Njideaka-Kevin T, Loh H, Lee V
Psychoradiology. 2024; 4:kkae015.
PMID: 39399446
PMC: 11467815.
DOI: 10.1093/psyrad/kkae015.
Neuroimaging markers of aberrant brain activity and treatment response in schizophrenia patients based on brain complexity.
Liu L, Li Z, Kong D, Huang Y, Wu D, Zhao H
Transl Psychiatry. 2024; 14(1):365.
PMID: 39251595
PMC: 11384759.
DOI: 10.1038/s41398-024-03067-8.
Brief Cognitive Behavioral Therapy for Depression and Anxiety in Patients with Schizophrenia in Psychiatric Home Nursing Service: Pilot Randomized Controlled Trial.
Katsushima M, Shimizu E
Behav Sci (Basel). 2024; 14(8).
PMID: 39199076
PMC: 11351661.
DOI: 10.3390/bs14080680.
Investigating the effects of antipsychotic drugs as a treatment for improving the activity of the /Dpysl2 gene in .
Miranda M, Hyde J, Salazar K, Bell B, Holgado A
MicroPubl Biol. 2024; 2024.
PMID: 39149410
PMC: 11325200.
DOI: 10.17912/micropub.biology.001063.
The Prevalence of Self-injurious Behavior in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis.
Lorentzen E, Mors O, Kjaer J
Schizophr Bull Open. 2024; 3(1):sgac069.
PMID: 39144767
PMC: 11206068.
DOI: 10.1093/schizbullopen/sgac069.
Investigating the Impacts of Diet, Supplementation, Microbiota, Gut-Brain Axis on Schizophrenia: A Narrative Review.
Zajkowska I, Niczyporuk P, Urbaniak A, Tomaszek N, Modzelewski S, Waszkiewicz N
Nutrients. 2024; 16(14).
PMID: 39064675
PMC: 11279812.
DOI: 10.3390/nu16142228.
The Use of Ascorbic Acid in Adjunctive Treatment for Schizophrenia-Current State of Knowledge.
Pilat P, Nikel K, Smolarczyk J, Piegza M
Life (Basel). 2024; 14(7).
PMID: 39063582
PMC: 11278382.
DOI: 10.3390/life14070828.
Establishment of a Mitochondrial Metabolism-Related Diagnostic Model in Schizophrenia Based on LASSO Algorithm.
Liu Y, Lin H, Liu M, Lin L, Wen Y
Psychiatry Investig. 2024; 21(6):618-628.
PMID: 38960439
PMC: 11222072.
DOI: 10.30773/pi.2024.0011.
Development of a simultaneous LC-MS/MS analytical method for plasma: 16 antipsychotics approved in Japan and 4 drug metabolites.
Maekawa M, Yokota M, Sato T, Sato Y, Kumondai M, Sato Y
Anal Sci. 2024; 40(9):1749-1763.
PMID: 38918311
PMC: 11358186.
DOI: 10.1007/s44211-024-00619-2.
Implementing an evidence-based behavioral weight-loss program in community mental health centers: A randomized pilot study.
Gudzune K, Jerome G, Goldsholl S, Dalcin A, Gennusa 3rd J, Fink T
Obes Sci Pract. 2024; 10(3):e760.
PMID: 38765556
PMC: 11099709.
DOI: 10.1002/osp4.760.
The role of the immune system in early-onset schizophrenia: identifying immune characteristic genes and cells from peripheral blood.
Chen Z, Li Y, Gao Y, Fan X, Du X, Li X
BMC Immunol. 2024; 25(1):26.
PMID: 38702611
PMC: 11067251.
DOI: 10.1186/s12865-024-00618-y.
Uncinate fasciculus microstructural organisation and emotion recognition in schizophrenia: controlling for hit rate bias.
Stevens M, Ni Mhurchu S, Corley E, Egan C, Hallahan B, McDonald C
Front Behav Neurosci. 2024; 18:1302916.
PMID: 38566859
PMC: 10985192.
DOI: 10.3389/fnbeh.2024.1302916.
Exploration of Positive and Negative Schizophrenia Symptom Heterogeneity and Establishment of Symptom-Related miRNA-mRNA Regulatory Network: Based on Transcriptome Sequencing Data.
Jin M, Xie M, Dong L, Xue F, Li W, Jiang L
Mol Neurobiol. 2024; 61(8):5992-6012.
PMID: 38267752
DOI: 10.1007/s12035-024-03942-x.